Organoids and Spheroids Market Size, Share, By Type (Organoids, Spheroids), By Application (Personalized Medicine, Drug Toxicity and Efficacy Testing, Developmental Biology, Disease Pathology Studies, Regenerative Medicine, and Others), By End-User (Academic and Research Institute, Hospitals and Diagnostic Centres, Pharmaceutical Industries and Others), and By Region – Market Trends, Analysis and Forecast till 2034

Report Code: PMI494722 | Publish Date: May 2024 | No. of Pages: 176

Organoids And Spheroids Market Companies

Recent News:

In February 2023, TheWell Bioscience, a provider of innovative solutions for cell culture and tissue engineering, announced the launch of its new product, VitroGel Organoid Recovery Solution. This solution is designed to facilitate rapid and safe harvesting of organic matter and cells, resulting in high yields. With the VitroGel Organoid Recovery solution, researchers can now effectively recover organoids and cells from the gel matrix without affecting their viability or function. This revolutionary technology is expected to significantly improve the productivity and efficiency of cell and cell culture processes, allowing researchers to accelerate medical research and discovery Regeneration, drug development and disease modeling.
In October 2022, AIM Biotech Pte. OrganiX System Publishing Company Limited. Organoids can benefit from angiogenic and immunogenic properties using this technique, thereby extending their shelf life during research.
In May 2021, Crown Bioscience, a global drug discovery and development services company, announced the acquisition of OcellO B.V., a Netherlands-based company specializing in drug discovery services based on organoids for oncological and immunological indications. The acquisition aims to expand Crown Bioscience's offering of preclinical in vitro drug development services, particularly in the areas of oncology and immunology, while strengthening the company's position in the agency market is growing.